EP 1999114 B1 20150722 - PYRAZOLES AS 11-BETA-HSD-1
Title (en)
PYRAZOLES AS 11-BETA-HSD-1
Title (de)
PYRAZOLE ALS 11-BETA-HSD1
Title (fr)
PYRAZOLES EN TANT QUE 11-BETA-HSD-1
Publication
Application
Priority
- EP 2007052269 W 20070312
- US 78483106 P 20060322
- US 87527406 P 20061215
Abstract (en)
[origin: US2007225280A1] Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, type II diabetes mellitus and metabolic syndrome.
IPC 8 full level
C07D 231/12 (2006.01); C07D 231/16 (2006.01); C07D 231/38 (2006.01); C07D 401/04 (2006.01); C07D 403/04 (2006.01); C07D 407/14 (2006.01); C07D 413/04 (2006.01); C07D 417/04 (2006.01)
CPC (source: EP KR NO US)
A61K 31/4155 (2013.01 - NO); A61P 3/00 (2017.12 - EP); A61P 3/04 (2017.12 - EP); A61P 3/10 (2017.12 - EP); A61P 43/00 (2017.12 - EP); C07D 231/12 (2013.01 - EP KR US); C07D 231/14 (2013.01 - NO); C07D 231/16 (2013.01 - EP US); C07D 231/38 (2013.01 - EP NO US); C07D 401/04 (2013.01 - EP KR NO US); C07D 403/02 (2013.01 - EP US); C07D 403/04 (2013.01 - EP NO US); C07D 407/14 (2013.01 - EP KR US); C07D 413/04 (2013.01 - EP NO US); C07D 417/04 (2013.01 - EP KR US)
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR
Designated extension state (EPC)
HR RS
DOCDB simple family (publication)
US 2007225280 A1 20070927; US 7728029 B2 20100601; AR 059983 A1 20080514; AU 2007228887 A1 20070927; AU 2007228887 B2 20120202; BR PI0708974 A2 20110621; CA 2645856 A1 20070927; CA 2645856 C 20110920; CN 101405270 A 20090408; CN 101405270 B 20130116; CR 10288 A 20081006; DK 1999114 T3 20150803; EC SP088747 A 20081031; EP 1999114 A2 20081210; EP 1999114 B1 20150722; EP 2295411 A1 20110316; ES 2548002 T3 20151013; HK 1130780 A1 20100108; HR P20151078 T1 20151120; HU E026011 T2 20160530; IL 193900 A 20130829; JP 2009530343 A 20090827; JP 5031817 B2 20120926; KR 101077366 B1 20111026; KR 20090005015 A 20090112; KR 20110007258 A 20110121; MA 30344 B1 20090401; MX 2008012017 A 20081001; MY 149622 A 20130913; NO 20083863 L 20081203; NO 341746 B1 20180115; NZ 570973 A 20111125; PL 1999114 T3 20151231; PT 1999114 E 20151016; RS 54216 B1 20151231; RU 2008141434 A 20100427; RU 2010119648 A 20111127; RU 2402517 C2 20101027; RU 2470016 C2 20121220; SG 155961 A1 20091029; SI 1999114 T1 20151030; TW 200806651 A 20080201; TW 201103916 A 20110201; TW I351403 B 20111101; WO 2007107470 A2 20070927; WO 2007107470 A3 20071108
DOCDB simple family (application)
US 71799607 A 20070314; AR P070101126 A 20070320; AU 2007228887 A 20070312; BR PI0708974 A 20070312; CA 2645856 A 20070312; CN 200780009748 A 20070312; CR 10288 A 20080916; DK 07726783 T 20070312; EC SP088747 A 20080918; EP 07726783 A 20070312; EP 10175020 A 20070312; EP 2007052269 W 20070312; ES 07726783 T 20070312; HK 09108733 A 20090924; HR P20151078 T 20151012; HU E07726783 A 20070312; IL 19390008 A 20080904; JP 2009500818 A 20070312; KR 20087025604 A 20070312; KR 20107029250 A 20070312; MA 31307 A 20081020; MX 2008012017 A 20070312; MY PI20083704 A 20070312; NO 20083863 A 20080909; NZ 57097307 A 20070312; PL 07726783 T 20070312; PT 07726783 T 20070312; RS P20150580 A 20070312; RU 2008141434 A 20070312; RU 2010119648 A 20070312; SG 2009063355 A 20070312; SI 200731685 T 20070312; TW 96109371 A 20070319; TW 99133403 A 20070319